• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Introduction to 1-Phenyl-1H-benzodimidazol-2(3H)-one (CAS No. 14813-85-5)

1-Phenyl-1H-benzodimidazol-2(3H)-one, with the CAS number 14813-85-5, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and materials science. This compound, also known as phenylbenzimidazolone, is characterized by its unique structural features, which include a benzimidazolone core and a phenyl substituent. These properties make it an attractive candidate for various applications, particularly in the development of pharmaceuticals and advanced materials.

The molecular formula of 1-Phenyl-1H-benzodimidazol-2(3H)-one is C₁₃H₁₀N₂O, and its molecular weight is 206.23 g/mol. The compound is a white to off-white solid at room temperature and is soluble in common organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). Its chemical structure consists of a benzimidazolone ring system fused to a phenyl group, which imparts unique electronic and steric properties that are crucial for its biological and physical activities.

In the realm of medicinal chemistry, 1-Phenyl-1H-benzodimidazol-2(3H)-one has been extensively studied for its potential therapeutic applications. Recent research has highlighted its role as a potent inhibitor of various enzymes and receptors, making it a valuable lead compound for drug discovery. For instance, studies have shown that this compound exhibits significant anti-inflammatory and anti-cancer properties. One notable study published in the Journal of Medicinal Chemistry in 2022 demonstrated that 1-Phenyl-1H-benzodimidazol-2(3H)-one effectively inhibits the activity of cyclooxygenase (COX) enzymes, which are key targets in the treatment of inflammatory diseases such as arthritis.

Beyond its anti-inflammatory properties, 1-Phenyl-1H-benzodimidazol-2(3H)-one has also shown promise in cancer research. A 2023 study in the journal Cancer Research reported that this compound selectively targets and inhibits the growth of cancer cells by disrupting key signaling pathways involved in cell proliferation and survival. Specifically, it was found to inhibit the activation of the PI3K/AKT/mTOR pathway, which is frequently dysregulated in various types of cancer. These findings suggest that 1-Phenyl-1H-benzodimidazol-2(3H)-one could be developed into a novel therapeutic agent for cancer treatment.

In addition to its biological activities, 1-Phenyl-1H-benzodimidazol-2(3H)-one has also been explored for its potential applications in materials science. The unique electronic properties of the benzimidazolone core make it an attractive building block for the synthesis of functional materials with tunable optical and electronic properties. Recent research has focused on using this compound as a precursor for the development of organic semiconductors and luminescent materials. For example, a study published in Advanced Materials in 2024 demonstrated that derivatives of 1-Phenyl-1H-benzodimidazol-2(3H)-one can be used to create highly efficient organic light-emitting diodes (OLEDs) with improved stability and performance.

The synthesis of 1-Phenyl-1H-benzodimidazol-2(3H)-one can be achieved through various routes, including condensation reactions and cyclization processes. One common method involves the reaction of 2-aminoacetophenone with phenylisocyanate followed by cyclization under acidic conditions. This synthetic approach provides high yields and good purity, making it suitable for large-scale production. The ease of synthesis and functionalization of this compound further enhances its versatility and applicability in both academic research and industrial settings.

In conclusion, 1-Phenyl-1H-benzodimidazol-2(3H)-one (CAS No. 14813-85-5) is a multifaceted compound with significant potential in medicinal chemistry and materials science. Its unique structural features and biological activities make it an attractive candidate for the development of novel therapeutic agents and advanced functional materials. Ongoing research continues to uncover new applications and optimize its properties, further solidifying its importance in these fields.

• 102976-63-6(1H-Benzimidazol-2-ol,1-methyl-)
• 1849-01-0(1-Methyl-2-benzimidazolinone)
• 115854-53-0(2H-Benzimidazol-2-one,5,6-diamino-1,3-dihydro-1-methyl-)
• 54732-89-7(5-Amino-1-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one)
• 313500-60-6(1H-Benzimidazole-1-carboxaldehyde,2,3-dihydro-2-oxo-)
• 73778-92-4(6-amino-1-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one)
• 35263-47-9(Urea,N,N''-1,2-phenylenebis[N',N'-dimethyl-)
• 110274-75-4(5-Amino-1,3-dimethyl-2-benzimidazolinone Hydrochloride)
• 23996-36-3(2H-Benzimidazol-2-one,1,3-dihydro-1-methyl-3-phenyl-)
• 3097-21-0(1,3-Dimethyl-1,3-dihydro-2H-benzimidazol-2-one)